Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 002132.SZ
Valuation Weak
14%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
17%
Per Share Metrics Bad
0%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -0.96 0.84 0.84
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 419.28 217.30 41.85
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -6.42 2.65 2.83
Cash -8.63 0.66 0.72
Capex -23.06 -0.06 0.07
Free Cash Flow -88.06 -0.03 0.24
Revenue -17.09 0.81 0.97
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -5.51 0.09 0.09
Operating Margin 71.41 < 0.005 < 0.005
ROA 12.68 < 0.005 < 0.005
ROE 11.15 < 0.005 < 0.005
ROIC 111.95 < 0.005 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 002132.SZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 002132.SZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 002132.SZ is permitted for members.